Rantac is a brand name for the drug ranitidine [1]. Ranitidine is an H2 blocker that reduces the amount of acid produced in the stomach [2]. It is used to treat and prevent ulcers in the stomach and intestines and to treat gastroesophageal reflux disease (GERD) [2].
What is Ranitidine Used For?
Ranitidine is prescribed for conditions involving excess stomach acid, including treating and preventing ulcers in the stomach and duodenum. It also addresses gastroesophageal reflux disease (GERD), a condition where stomach acid frequently flows back into the esophagus [2].
When Did Ranitidine Become Available?
Ranitidine was first marketed in the early 1980s [3].
Why Was Ranitidine Removed from the Market?
In 2019, concerns arose regarding the presence of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, in ranitidine products. This led to voluntary recalls by manufacturers and eventual market withdrawal by regulatory agencies like the U.S. Food and Drug Administration (FDA) in April 2020 [4][5]. The NDMA impurity was found to form over time in the drug itself [4].
What Alternatives Are There to Ranitidine?
Following the withdrawal of ranitidine, alternative medications are available for conditions it previously treated. These include other H2 blockers such as famotidine (Pepcid) and cimetidine (Tagamet), as well as proton pump inhibitors (PPIs) like omeprazole (Prilosec), lansoprazole (Prevacid), and esomeprazole (Nexium) [6][7].
Can You Still Get Ranitidine?
Ranitidine products are no longer available in major markets like the United States and Europe due to safety concerns related to NDMA contamination [4][5].
What is the Difference Between Brand Name and Generic Ranitidine?
Rantac is a specific brand name under which ranitidine was sold. Generic ranitidine refers to the same active ingredient, ranitidine, produced by different manufacturers after the patent expired. However, due to the market withdrawal of ranitidine, neither brand-name nor generic versions are currently widely available [1][5].
What Are the Risks Associated with Ranitidine?
The primary risk that led to ranitidine's withdrawal was the presence of NDMA, a probable human carcinogen [4]. Studies indicated that NDMA could form in ranitidine products over time [4].
Which Companies Made Ranitidine?
Before its withdrawal, ranitidine was manufactured and marketed by various pharmaceutical companies under different brand names, with Rantac being one such brand [1]. Major manufacturers included GlaxoSmithKline (originally) and generic drug producers [3].
Sources:
1. DrugPatentWatch.com
2. National Institute of Diabetes and Digestive and Kidney Diseases
3. PubMed Central
4. U.S. Food and Drug Administration
5. European Medicines Agency
6. Mayo Clinic
7. American College of Gastroenterology